semaglutide before and after 1 year 3 Stories from Real Patients 1 Year On A GLP1

Always replace the pen cap after use to protect it from light

Neither temperature extreme is compatible with GLP-1 medications

This simple touch made a real difference

It is beneficial to keep fingernails short and clean to avoid introducing allergens and risking infection

Semaglutide led to a significant reduction in HbA1c levels compared to placebo- Patients receiving semaglutide experienced significant weight loss compared to those on placebo PIONEER Trials (Peptide Innovation for Early Diabetes Treatment): The PIONEER (Peptide Innovation for Early Diabetes Treatment) trials were a series of global, randomized, controlled clinical trials that investigated the efficacy, safety, and tolerability of oral semaglutide, a GLP-1 receptor agonist, in patients with type 2 diabetes

The WHOs VigiBase confirmed these risks with even higher reporting odds ratios, including an ROR of 68.58 for ischemic optic neuropathy